相似文献
1
Lucentis excluded from WHO list of essential medicines.
BMJ. 2015 May 13;350:h2573. doi: 10.1136/bmj.h2573.
2
US ophthalmologists plead with drug regulator not to restrict access to Avastin.
BMJ. 2015 Mar 5;350:h1266. doi: 10.1136/bmj.h1266.
3
The selection and use of essential medicines. Report of the WHO expert committee, 2005 (including the 14th model list of essential medicines).
World Health Organ Tech Rep Ser. 2006(933):1-119, back cover.
4
The selection and use of essential medicines.
World Health Organ Tech Rep Ser. 2008(950):backcover, vii-174.
5
The selection and use of essential medicines.
World Health Organ Tech Rep Ser. 2014(985):i-xiv, 1-219, back cover.
6
The selection and use of essential medicines.
World Health Organ Tech Rep Ser. 2011(965):i-xiv, 1-249.
7
[Avastin and Lucentis for macular degeneration].
Rev Med Suisse. 2012 Aug 29;8(351):1636-7.
8
The Selection and Use of Essential Medicines.
World Health Organ Tech Rep Ser. 2015(994):vii-xv, 1-546.
9
Handle avastin and lucentis with care.
Insight. 2013 Fall;38(4):14.
10
Picture of the month: anterior chamber cholesterolosis in Coats disease.
Arch Pediatr Adolesc Med. 2011 Dec;165(12):1131-2. doi: 10.1001/archpediatrics.2011.190-a.
Zotero 插件